| Literature DB >> 27835659 |
Célia Regina de Oliveira Bittencourt1, Maria Cristina de Oliveira Izar1, Valdir Lauro Schwerz1, Rui Manuel Dos Santos Póvoa1, Henrique Andrade Rodrigues Fonseca1, Marília Izar Helfenstein Fonseca1, Henrique Tria Bianco1, Carolina Nunes França1,2, Carlos Eduardo Dos Santos Ferreira1,3, Francisco Antonio Helfenstein Fonseca1.
Abstract
To evaluate the effects of long-term exposure to high-intensity training among professional runners on cardiac hypertrophy and subclinical atherosclerosis. Prospective study included runners of both sexes (n = 52) and age and gender matched controls (n = 57), without classical cardiovascular risk factors. Ventricular hypertrophy was quantified by echocardiography by linear method and carotid intima-media thickness (cIMT) by 2-D images obtained by ultrasonography. Endothelial function was evaluated by flow-mediated dilation (FMD). Steroid hormones were quantified by HPLC followed by LC-MS/MS. Higher left ventricular (LV) mass index was found in male athletes (p<0.0001 vs. other groups). When adjusted for gender, the degree of left ventricular mass index classified as mildly, moderately or severely abnormal was obtained in 26%, 35%, and 30%, respectively, of female athletes, and in 39%, 14%, and 21%, respectively, of male athletes. Higher ratio of the early (E) to late (A) ventricular filling velocities was found in athletes of both genders. Male athletes presented lower cIMT in the right (p = 0.012 vs. male controls) and left (p<0.0001 vs. male controls) common carotid arteries, without differences in cIMT between female athletes and controls. FMD results were similar among groups. Higher serum testosterone levels were found in male athletes (p<0.0001 vs. other groups) and they were correlated with LV mass (r = 0.50, p<0.0001). The chronic exposure of high-intensity training among professional runners of both genders was associated with increased ventricular mass and adaptive remodeling. Less subclinical atherosclerosis was found in male athletes. Differences in steroid hormones may account in part for these findings.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27835659 PMCID: PMC5106016 DOI: 10.1371/journal.pone.0166009
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Major characteristics of study population, by group.
| Age, years | 30 (6) | 34 (7) | 33 (7) | 31 (8) | 0.15 |
| Weight, kg | 61 (5) | 85 (15) | 51 (6) | 65 (14) | <0.001 |
| BMI, kg/m2 | 21 (1) | 27 (4) | 20 (1) | 26 (5) | <0.001 |
| Glucose, mg/dL | 85 (7) | 91 (9) | 84 (8) | 87 (9) | 0.008 |
| TC, mg/dL | 152 (27) | 188 (35) | 170 (26) | 181 (39) | <0.001 |
| HDL-C, mg/dL | 59 (13) | 47 (11) | 72 (15) | 61 (14) | <0.001 |
| LDL-C, mg/dL | 85 (19) | 117 (30) | 86 (25) | 105 (34) | <0.001 |
| TG, mg/dL | 53 (16) | 117 (63) | 58 (19) | 75 (27) | <0.001 |
| hsCRP, mg/L | 1.2 (1.4) | 2.5 (3.0) | 1.6 (2.3) | 3.4 (4.8) | 0.056 |
| ApoA1, mg/dL | 151 (20) | 133 (19) | 163 (20) | 149 (26) | <0.001 |
| ApoB, mg/dL | 70 (14) | 99 (27) | 70 (17) | 83 (23) | <0.001 |
| FMD, % | 14.4 (10.7) | 9.2 (5.2) | 13.1 (12.6) | 17.8 (13.8) | 0.325 |
| Systolic BP, mm Hg | 111 (13) | 116 (11) | 109 (19) | 106 (10) | 0.081 |
| Diastolic BP, mm Hg | 68 (10) | 74(8) | 61 (19) | 69 (8) | 0.001 |
| Heart rate, bpm | 59 (9) | 72 (9) | 59 (8) | 76 (10) | <0.0001 |
| Diet, kcal/day | 2883 (915) | 2113 (707) | 2298 (824) | 1877 (702) | <0.0001 |
| Proteins, % | 18 (7) | 16 (5) | 18 (6) | 18 (6) | 0.716 |
| Carbohidrates, % | 69 (23) | 55 (9) | 61 (9) | 55 (9) | 0.009 |
| Fats, % | 28 (18) | 28 (7) | 21 (6) | 27 (7) | 0.298 |
| Fibers, g | 30 (14) | 20 (9) | 25 (20) | 17 (9) | 0.009 |
| Androstenedione | 75 (25) | 62 (23) | 92 (42) | 103 (58) | 0.019 |
| 11-deoxycortisol | 35 (43) | 32 (28) | 19 (10) | 19 (13) | 0.255 |
| Testosterone | 539 (192) | 359 (182) | 22 (14) | 25 (13) | <0.000 |
| 17-α Hydroxyprogesterone | 97 (59) | 51 (24) | 96 (75) | 55 (55) | 0.016 |
| Corticosterone | 333 (275) | 256 (205) | 222 (149) | 189 (147) | 0.152 |
Values are mean (SD). TC–total cholesterol; TG–triglycerides; hsCRP–highly-sensitive C-reactive protein; FMD–flow-mediated dilation; BP–blood pressure; Sex hormones are ng/dL.
Comparisons were made by ANOVA-Tukey.
aMale controls > other groups; female controls > female athletes; male athletes > female athletes
bMale controls > other groups; female controls > male and female athletes
cMale controls > female athletes
dMale athletes < female athletes and male controls
eMale controls < other groups; female athletes > other groups
fMale and female controls > male and female athletes
gMale controls > other groups
hMale controls < other groups
iMale controls > male and female athletes
jMale athletes > male and female controls
kMale athletes > female controls
lFemale controls > male controls
mMale athletes > other groups; male controls > female athletes and female controls.
Fig 1Carotid intima-media thickness, by study groups.
A- Right common carotid artery (RCCA). B- Left common carotid artery (LCCA). Comparisons were made by ANOVA-Tukey.
Echocardiographic parameters, by group.
| LA diameter, mm | 33 (3) | 35 (5) | 33 (4) | 33 (4) | 0.32 |
| LA volume, mm3 | 206 (24) | 192 (31) | 185 (17) | 170 (31) | <0.04 |
| RV, mm | 23 (5) | 19 (6) | 21 (5) | 19 (4) | 0.052 |
| LV systolic, mm | 34 (3) | 29 (5) | 30 (3) | 29 (4) | <0.001 |
| LV diastolic, mm | 52 (3) | 48 (5) | 49 (4) | 48 (6) | <0.004 |
| Septum wall, mm | 11 (1) | 9 (1) | 10 (1) | 9 (2) | <0.0001 |
| Posterior wall, mm | 9 (1) | 8 (1) | 8 (1) | 8 (1) | <0.002 |
| IVRT, msec | 105 (18) | 90 (14) | 98 (16) | 87 (13) | <0.0001 |
| LV mass, g | 229 (43) | 163 (58) | 173 (28) | 162 (65) | <0.0001 |
| Mass index, g/m2 | 132 (24) | 86 (24) | 116 (14) | 87 (26) | <0.0001 |
| Aorta, mm | 25 (3) | 27 (4) | 22 (3) | 25 (4) | <0.0001 |
| LVEF, %, | 64 (6) | 69 (8) | 67 | 70 (6) | 0.002 |
| E/A ratio, | 2.0 (0.5) | 1.4 (0.4) | 2.0 (0.6) | 1.7 (0.5) | 0.002 |
| E’/A’ ratio, | 1.7 (0.4) | 1.5 (0.6) | 2.0 (0.6) | 1.7 (0.5) | 0.035 |
| E/e’ ratio, | 6.4 (1.0) | 6.3 (1.1) | 6.8 (1.4) | 6.4 (1.5) | 0.594 |
Values are mean and standard deviation (SD). LA–left atrium; RV–right ventricule; LV–left ventricular; IVRT–Isovolumic relaxation time; LVEF–Left ventricular ejection fraction; E/A—the ratio of the early (E) to late (A) ventricular filling velocities; E’/A’- early (E′) and late (A′) peak velocities of septal and lateral mitral annulus; E/e’- early mitral inflow velocity (E) and mitral anular early diastolic velocity (e’) ratio.
Comparisons were made by ANOVA-Tukey.
aMale athletes > female athletes and female controls
bMale controls > other groups
cMale athletes > male and female controls
dFemale controls < other groups; female athletes < male athletes and male controls
eMale athletes > other groups; female athletes > male controls and female controls
fFemale athletes < male athletes and male controls
gFemale controls > male athletes and female athletes
hMale and female athletes > male controls
iMale controls < other groups.
Fig 2Echocardiographic characteristics of the study population, by group.
A-Left ventricular mass index (LV mass index). B-Left ventricular Ejection Fraction (LVEF). C-Left ventricular mass (LV mass). D-Early (E) to late (A) ventricular filling velocities ratio (E/A ratio). Comparisons were made by ANOVA-Tukey.